14_Dec_18_Final_REDACTED_J&A_FOR_FBO_12_DEC_17_Redacted.pdf

the performance risk to the Government in having the compound synthesized, purified, and characterized again to meet the stipulated quality standards.

8. Efforts to obtain Competition: This requirement is exempt from publication in accordance with FAR 5.202(a)(2).

(b) Effective competition. The full requirement will be competed to select the vendors for the multi-award IDIQ.

(c) Subcontracting competition. N/A.

9. Actions to remove or overcome barriers Competition: The full requirement, a multi-award IDIQ for the synthesis, purification, and characterization of chemical compounds, is in the solicitation phase under PR #10967662 and will be fully competed. The Government has full confidence that this competition and award will be completed by the end of December 2017.

Therefore, future requirements for this compound will be competed among the awardees of the multi-award IDIQ

10. Market Survey: Market research was completed on the requirement identifying several potential offerors. However, it was determined that because of the specific compound required, and the urgency of the requirement, the recommended acquisition strategy for this requirement is a FFP sole-source award to Organix Incorporated. This company already has a synthesis route and risk management plan that was previously approved by the ET Branch.

11. Interested Sources: Under the previous award, the following vendors received awards:

• AAPharmaSyn LLC.

• Organix Incorporated

• Ash Stevens Inc

12. Procurement History and any other facts:

Previous Contract or Purchase Order Number: W81XWH-12-D-0029-0006, Period of

Performance, 5 Aug 2016-4 Nov 2016

Previously competed? This requirement was competed utilizing the three existing IDIQ contract holders. In August 2016, Organix Incorporated was awarded Task Order 0006 for this same requirement.

Previous authority for less than Full & Open Competition: N/A.